AA
Therapeutic Areas
Aditxt Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Adimune (ADi-001/002) | Type 1 Diabetes | Preclinical / Early Clinical |
| Adimune | Vitiligo | Preclinical |
| AditxtScore for COVID-19 | COVID-19 Immune Monitoring | Commercial/Development |
| Drug | Indication | Phase |
|---|---|---|
| Adimune (ADi-001/002) | Type 1 Diabetes | Preclinical / Early Clinical |
| Adimune | Vitiligo | Preclinical |
| AditxtScore for COVID-19 | COVID-19 Immune Monitoring | Commercial/Development |